14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $199.92 $199.92 Thursday, 14th Sep 2023 RXDX stock ended at $199.92. During the day the stock fluctuated 0% from a day low at $199.92 to a day high of $199.92.
90 days $199.92 $199.92
52 weeks $30.75 $199.96

Historical Prometheus Biosciences Inc prices

Date Open High Low Close Volume
Apr 27, 2021 $25.52 $25.52 $24.29 $25.19 71 630
Apr 26, 2021 $25.42 $26.69 $25.01 $25.25 139 666
Apr 23, 2021 $27.60 $28.47 $25.11 $25.41 119 024
Apr 22, 2021 $28.59 $30.62 $27.17 $27.76 130 058
Apr 21, 2021 $26.09 $29.50 $24.63 $28.69 230 883
Apr 20, 2021 $27.76 $27.89 $25.71 $26.40 90 943
Apr 19, 2021 $25.62 $27.89 $24.50 $27.80 98 391
Apr 16, 2021 $24.25 $26.24 $23.03 $25.99 85 728
Apr 15, 2021 $23.00 $24.56 $22.55 $24.55 132 201
Apr 14, 2021 $21.30 $22.89 $20.75 $22.48 129 695
Apr 13, 2021 $18.85 $22.53 $18.81 $21.28 211 659
Apr 12, 2021 $22.90 $22.90 $18.60 $18.80 204 244
Apr 09, 2021 $23.68 $23.73 $22.70 $22.91 165 984
Apr 08, 2021 $20.33 $22.89 $20.05 $22.70 405 931
Apr 07, 2021 $19.24 $19.40 $18.41 $19.40 141 724
Apr 06, 2021 $20.00 $20.00 $18.85 $18.85 103 891
Apr 05, 2021 $18.55 $19.46 $17.82 $19.08 173 276
Apr 01, 2021 $18.14 $18.95 $17.56 $18.18 154 056
Mar 31, 2021 $16.95 $18.72 $16.92 $18.26 130 558
Mar 30, 2021 $16.68 $17.22 $16.25 $16.77 184 221
Mar 29, 2021 $18.47 $18.47 $16.11 $16.51 201 516
Mar 26, 2021 $18.76 $19.98 $17.78 $18.03 95 345
Mar 25, 2021 $19.79 $19.79 $18.15 $18.70 168 151
Mar 24, 2021 $21.34 $21.42 $19.56 $19.60 62 559
Mar 23, 2021 $21.98 $22.11 $20.98 $21.42 81 873
Click to get the best stock tips daily for free!

About Prometheus Biosciences Inc

Prometheus Biosciences Prometheus Biosciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics and companion diagnostics products for the treatment of inflammatory bowel diseases (IBD). Its lead product includes PRA023, a humanized IgG1 monoclonal antibody (mAb), which is in Phase IIa clinical trial for the treatment of ulcerative colitis and Crohn's disease, as well as systemic sclerosis-associated ... RXDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT